These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 5094330

  • 1. Thromboembolism and oral contraceptives.
    Seigel DG.
    Obstet Gynecol; 1971 Sep; 38(3):478-80. PubMed ID: 5094330
    [Abstract] [Full Text] [Related]

  • 2. [Statement on the thromboembolic risk while taking oral contraceptives].
    Rozenbaum H.
    Therapeutique; 1970 Apr; 46(4):439-41. PubMed ID: 5427202
    [Abstract] [Full Text] [Related]

  • 3. [Side effects of oral contraceptives].
    Böttiger LE, Westerholm B.
    Lakartidningen; 1971 Sep 22; 68(39):4371-8. PubMed ID: 5130326
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6 and antiphospholipid antibodies in women with contraceptive-related thromboembolic disease.
    Salobir B, Sabovic M.
    Obstet Gynecol; 2004 Sep 22; 104(3):564-70. PubMed ID: 15339770
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.
    Thromb Haemost; 1997 Dec 22; 78(6):1480-3. PubMed ID: 9423798
    [Abstract] [Full Text] [Related]

  • 10. Estrogens and thromboembolic diseases. Present conception of a controversial issue.
    Zador G.
    Acta Obstet Gynecol Scand Suppl; 1976 Dec 22; 54():13-28. PubMed ID: 788441
    [No Abstract] [Full Text] [Related]

  • 11. Deaths among users of oral and nonoral contraceptives.
    Fuertes-de la Haba A, Cuevas JO, Pelegrina I, Bangdiwala I.
    Obstet Gynecol; 1970 Oct 22; 36(4):597-602. PubMed ID: 5506465
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM.
    Obstet Gynecol; 2007 Sep 22; 110(3):587-93. PubMed ID: 17766604
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC, Kay CR.
    Br J Gen Pract; 1998 Oct 22; 48(435):1657-62. PubMed ID: 10071398
    [Abstract] [Full Text] [Related]

  • 16. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E, Keller PJ.
    Praxis (Bern 1994); 1997 Oct 01; 86(40):1543-8. PubMed ID: 9417570
    [Abstract] [Full Text] [Related]

  • 17. Risks of oral contraceptive use in women over 35.
    Stenchever MA.
    J Reprod Med; 1993 Dec 01; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [Abstract] [Full Text] [Related]

  • 18. [Thromboembolic complications in the use of oral contraceptives].
    Lidegaard O.
    Ugeskr Laeger; 1997 Mar 24; 159(13):1908-9. PubMed ID: 9123625
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.